HGF and MET expression predicts survival in HPV-negative head and neck cancer
Elevated HGF and MET expression correlates with worse survival in HNSCC patients
Kaplan-Meier survival curves comparing rwOS for MET- and HGF-High/Low expressors in pre-treatment samples from HPV negative HNSCC patients anchored on 1L treatment. Shaded areas represent the 95% confidence intervals. Median survival times (months) are specified. Median MET and HGF expression was used to derive High/Low groups. Log-Rank test P value is indicated.
Lens Library
